🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase III trial compares the effect of sentinel lymph node mapping to ...
Status
Recruiting
Location
George Washington University Medical Center
Start Date
2022-12-07
Trial ID
NCT05646316
It is a prospective observational trial. Primary goal is identification of ...
Status
Unknown
Location
Università degli Studi della Campania Luigi Vanvitelli
Start Date
2022-12-10
Trial ID
NCT05657483
Treatments Being Tested
CYTOMARK, a non-invasive in vitro diagnostic (IVD) test measuring a defined...
Status
Recruiting
Location
Hospital Universitari de Bellvitge
Start Date
2024-06-24
Trial ID
NCT07148154
Treatments Being Tested
The current study aims to assess high-risk patients using both liquid-based...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-11-04
Trial ID
NCT06672341
Treatments Being Tested
This diagnostic trial is studying the presence of a specific protein as a p...
Status
Completed
Location
Gynecologic Oncology Group of Arizona
Start Date
1998-09
Trial ID
NCT00003384
Treatments Being Tested
This phase II ComboMATCH treatment trial compares selumetinib plus olaparib...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-04-25
Trial ID
NCT05554328
Based on the previous study of NCT04651738, we performed this trial to furt...
Status
Unknown
Location
Lei Li
Start Date
2022-03-12
Trial ID
NCT05290922
Treatments Being Tested
Prospective multicentric randomized trial to evaluate the role of uterine m...
Status
Unknown
Location
Division of Oncologic Gynecology, Fondazione Policlinico Gemelli
Start Date
2015-10
Trial ID
NCT02762214
Treatments Being Tested
This study is to find out how well liquid biopsies work as a non-invasive a...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2019-06-18
Trial ID
NCT05049538
Treatments Being Tested
To provide medical follow-up to patients exposed to BGG492 for more than 28...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-08
Trial ID
NCT02150213